Recent advances in drug discovery of GPCR allosteric modulators for neurodegenerative disorders

被引:15
|
作者
Lutjens, Robert [1 ]
Rocher, Jean-Philippe [2 ]
机构
[1] Addex Therapeut, Geneva, Switzerland
[2] Inst Rech Pierre Fabre, CNS Innovat Unit, Toulouse, France
关键词
METABOTROPIC GLUTAMATE RECEPTORS; PROTEIN-COUPLED RECEPTORS; AMYOTROPHIC-LATERAL-SCLEROSIS; LEVODOPA-INDUCED DYSKINESIAS; CENTRAL-NERVOUS-SYSTEM; PARKINSONS-DISEASE; MOUSE MODEL; ALZHEIMERS-DISEASE; CNS DISORDERS; L-DOPA;
D O I
10.1016/j.coph.2017.01.001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The activation or the inhibition of G-protein coupled receptors (GPCRs) implicated in the pathophysiology of neurodegenerative disorders is considered as a relevant approach for the treatment of these diseases. The modulation of the relevant GPCRs targets by positive or by negative allosteric modulators appears to be promising, the major challenge remaining the discovery of these molecules. In this review, we highlight the recent development in this field and the therapeutic potential of selected GPCRs allosteric modulators.
引用
收藏
页码:91 / 95
页数:5
相关论文
共 50 条
  • [1] Biased Allosteric Modulators: New Frontiers in GPCR Drug Discovery
    Slosky, Lauren M.
    Caron, Marc G.
    Barak, Lawrence S.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2021, 42 (04) : 283 - 299
  • [2] GPCR allosteric modulators: Opportunities and challenges for novel drug discovery
    Christopoulos, Arthur
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [3] Recent Advances in the Discovery of Nicotinic Acetylcholine Receptor Allosteric Modulators
    Manetti, Dina
    Dei, Silvia
    Arias, Hugo R.
    Braconi, Laura
    Gabellini, Alessio
    Teodori, Elisabetta
    Romanelli, Maria Novella
    MOLECULES, 2023, 28 (03):
  • [4] Drug Design Strategies for GPCR Allosteric Modulators
    Conn, P. Jeffrey
    Kuduk, Scott D.
    Doller, Dario
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 47, 2012, 47 : 441 - 457
  • [5] Recent Advances in the Discovery of Selective AMPA Receptor Positive Allosteric Modulators
    Ward, Simon E.
    Harries, Mark
    CURRENT MEDICINAL CHEMISTRY, 2010, 17 (30) : 3503 - 3513
  • [6] Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors
    Lindsley, Craig W.
    Emmitte, Kyle A.
    Hopkins, Corey R.
    Bridges, Thomas M.
    Gregory, Karen J.
    Niswender, Colleen M.
    Conn, P. Jeffrey
    CHEMICAL REVIEWS, 2016, 116 (11) : 6707 - 6741
  • [7] GPCR drug discovery through the exploitation of allosteric drug binding sites
    Rees, S
    Morrow, D
    Kenakin, T
    RECEPTORS & CHANNELS, 2002, 8 (5-6): : 261 - 268
  • [8] Recent advances in positive allosteric modulators of the AMPA receptor
    Morrow, John A.
    Maclean, John K. F.
    Jamieson, Craig
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2006, 9 (05) : 571 - 579
  • [9] New opportunities for GPCR allosteric modulators
    Topiol, Sid
    FUTURE MEDICINAL CHEMISTRY, 2018, 10 (07) : 707 - 710
  • [10] Recent advances in the development of allosteric protein tyrosine phosphatase inhibitors for drug discovery
    Elhassan, Reham M.
    Hou, Xuben
    Fang, Hao
    MEDICINAL RESEARCH REVIEWS, 2022, 42 (03) : 1064 - 1110